Gender | ||
---|---|---|
Male | Female | |
Life impact (%) | ||
Median | 66.67 | 66.67 |
IQR | 33.33–66.67 | 33.33–66.67 |
Mean rank | 435.09 | 428.63 |
p value | 0.687 | |
Risk factors (%) | ||
Median | 50 | 50 |
IQR | 33.33–66.67 | 33.33–66.67 |
Mean rank | 433.58 | 429.84 |
p value | 0.822 | |
Symptoms (%) | ||
Median | 50 | 50 |
IQR | 25–75 | 25–75 |
Mean rank | 420.18 | 440.55 |
p value | 0.214 | |
Treatment (%) | ||
Median | 75 | 75 |
IQR | 50–75 | 50–75 |
Mean rank | 426.26 | 435.69 |
p value | 0.563 | |
Assessment (%) | ||
Median | 75 | 50 |
IQR | 50–75 | 50–75 |
Mean rank | 444.55 | 421.06 |
p value | 0.149 | |
Care giving (%) | ||
Median | 60 | 60 |
IQR | 40–80 | 40–80 |
Mean rank | 436.12 | 427.80 |
p value | 0.614 | |
Course of the disease (%) | ||
Median | 50 | 50 |
IQR | 50–75 | 50–75 |
Mean rank | 416.45 | 443.53 |
p value | 0.094 |